General overview
The Hospital Pharmacy Department (PUI) of Gustave Roussy is responsible, in accordance with the French Public Health Code and HAS/ARS standards, for the complete management of the medication-use process and sterile medical devices, the pharmaceutical validation of prescriptions, the production of cytotoxic drugs and other hospital preparations, the contribution to clinical research, and the provision of information to healthcare professionals and patients.
With more than 100,000 chemotherapy preparations per year and over 500 clinical trials involving pharmacy activities, the department is a key component of comprehensive oncology care.
Organisation of the clinical pharmacy department
Research and Clinical Service (Prof. Bernard Do – acting head)
- Radiopharmacy
- Clinical trials
- Pharmaceutical technology and pharmaceutical innovation (includes the development of tailored dosage forms and innovation in personalised medicine)
- Clinical pharmacy and prescription validation (a cross-cutting activity across the department)
Production and Logistics Service (Dr Amélie Gaudin)
- Procurement and management of medicines and medical devices
- Sterilisation of reusable medical devices
- Centralised endoscope disinfection
- Centralised chemotherapy production unit
Key missions
- Procurement and management of health products
Purchasing, storage and distribution of medicines, medical devices, infusion solutions and antiseptics; regulatory management of controlled substances; anticipation and management of shortages. - Production and quality control
Centralised preparation of chemotherapy (full traceability, operating 6 days/week); pharmaceutical technology (hospital-only oral and injectable formulations, repackaging); physico-chemical and microbiological quality control. - Reusable medical devices
Oversight of outsourced sterilisation services for reusable medical devices (surgical instruments); centralised endoscope disinfection. - Clinical research and innovation
Pharmaceutical coordination of more than 500 active clinical trials; radiopharmacy; innovative pharmaceutical technology; integration of advanced technologies (including 3D pharmaceutical printing) into hospital workflows. - Clinical pharmacy and validation
Systematic pharmaceutical validation of prescriptions, support and advice to clinical teams, therapeutic drug monitoring, participation in multidisciplinary meetings and tumour boards. - Quality and vigilance
Quality assurance approach coordinated by a transversal unit; monitoring of vigilance systems (pharmacovigilance, materiovigilance, etc.); continuing professional development and training.
Patient services
- Location: Level -1, Room 103
- Outpatient dispensing hours: Monday–Friday, 9:30 am–6:00 pm
- Dispensing of medications
- Coordination between hospital and community care
Key figures
- More than 100,000 chemotherapy preparations per year
- Over 500 active clinical trials
- Integrated capacity for hospital-based development of innovative medicines and solutions for personalised medicine
